within Pharmacolibrary.Drugs.ATC.M;

model M01AE53
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 60 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,
    adminCount     = 1,
    Vd             = 0.01,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Ketoprofen is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain, inflammation, and fever. Formulations under ATC code M01AE53 are combinations of ketoprofen with other substances, typically used for enhanced analgesic effects in musculoskeletal and joint disorders. While ketoprofen is still approved and in clinical use, specific combination products and their usage may vary between countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a typical adult (healthy volunteer, both sexes, 18-55 years) based on known data of oral ketoprofen and general knowledge about NSAID combinations. No published population PK data was found specifically for ketoprofen combinations under M01AE53.</p><h4>References</h4><ol><li><p>Medina-López, R, et al., &amp; López-Muñoz, FJ (2018). Pharmacokinetics and Pharmacodynamics of (S)-Ketoprofen Co-Administered with Caffeine: A Preclinical Study in Arthritic Rats. <i>Pharmaceutics</i> 10(1) –. DOI:<a href=&quot;https://doi.org/10.3390/pharmaceutics10010020&quot;>10.3390/pharmaceutics10010020</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29373537/&quot;>https://pubmed.ncbi.nlm.nih.gov/29373537</a></p></li><li><p>García, ML, et al., &amp; Mauleón, D (1998). Bioavailability of S(+)-ketoprofen after oral administration of different mixtures of ketoprofen enantiomers to dogs. <i>Journal of clinical pharmacology</i> 38(S1) 22S–26S. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9882078/&quot;>https://pubmed.ncbi.nlm.nih.gov/9882078</a></p></li><li><p>Guarino, V, et al., &amp; Ambrosio, L (2018). Core/shell cellulose-based microspheres for oral administration of Ketoprofen Lysinate. <i>Journal of biomedical materials research. Part B, Applied biomaterials</i> 106(7) 2636–2644. DOI:<a href=&quot;https://doi.org/10.1002/jbm.b.34080&quot;>10.1002/jbm.b.34080</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29377599/&quot;>https://pubmed.ncbi.nlm.nih.gov/29377599</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end M01AE53;
